SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001213900-24-044071
Filing Date
2024-05-16
Accepted
2024-05-16 10:26:17
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 TO FORM SC 13G ea0206277-13ga2schneid_gale.htm SC 13G/A 51692
  Complete submission text file 0001213900-24-044071.txt   53002
Mailing Address 45 LIBERTY BLVD. SUITE 230 MALVERN PA 19355
Business Address 45 LIBERTY BLVD. SUITE 230 MALVERN PA 19355 610-725-1500
Galera Therapeutics, Inc. (Subject) CIK: 0001563577 (see all company filings)

IRS No.: 461454898 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91201 | Film No.: 24953901
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1 WOOD LANE SUFFERN NY 10901
Business Address
Schneid Yair (Filed by) CIK: 0002008233 (see all company filings)

Type: SC 13G/A